ADCAN Pharma is a leading UAE-based pharmaceutical manufacturer headquartered in Abu Dhabi, proudly supporting the UAE’s Vision 2030 and the “Make it in the Emirates” initiative to build a world-class healthcare ecosystem and enhance in-country value (ICV). As the first and only Oncology and Hormones manufacturer in the UAE, we are committed to delivering high-quality, affordable, Made-in-UAE medicines that meet stringent international standards. Our products hold GMP certifications from authorities including MOHAP/EDE (UAE), SFDA (Saudi Arabia), and others across the region. Our portfolio encompasses major therapeutic areas, including Oncology, Hormones and General medications. Established in response to the rapid growth of the GCC pharmaceutical market, we operate state-of-the-art, cGMP-compliant manufacturing facilities in ICAD (Industrial City of Abu Dhabi), equipped with advanced technology and dedicated areas for innovation. With a strong focus on quality, patient care, research & development, and operational excellence, ADCAN Pharma is positioned as a trusted partner in the MENA region — exporting to multiple markets while contributing to regional medicines security and healthcare innovation. We are passionate about improving lives through science-driven solutions and building a healthier future for patients, healthcare professionals, and communities across the region and beyond. Website: www.adcanpharma.ae Follow us for updates on our journey toward pharmaceutical excellence!
| Website | https://www.adcanpharma.ae |
| Revenue | $19.3 million |
| Employees | 151 (120 on RocketReach) |
| Founded | 2015 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical Products, Pharma Sales, Healthcare Market, Prescription Drugs, Drug Marketing, Generic Medications, Medical Supplies, Biotechnology, Drug Distribution, Pharmaceutical Marketing, Healthcare Solutions, Pharmacy Services, Medical Devices, Medicine Supply, Drug Development, Clinical Trials, Pharmaceutical Research, Regulatory Affairs, Drug Manufacturing, Health Solutions |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, Bayer, GSK, AstraZeneca +40 more (view full list) |
Looking for a particular ADCANPharma employee's phone or email?
The ADCANPharma annual revenue was $19.3 million in 2026.
Fokion Sinis is the CEO of ADCANPharma.
120 people are employed at ADCANPharma.